(1) is easy: You announce the existence of the program so you can say you're doing it for "everyone" and you aren't price gouging anymore, you then never mentio

(1) is easy: You announce the existence of the program so you can say you're doing it for "everyone" and you aren't price gouging anymore, you then never mention it again, don't document it, don't market it, and then if someone does still remember it make it hard to enroll or add a bunch of non-monetary expenses to make it as unpalatable as possible. If it's only for the uninsured you can bet that insurance companies will continue to have to pay full [insurance co] price and bake that cost into everyone's premiums. It's bizarre that price gouging laws apparently don't apply to medicine - I get that there are a bunch of treatments where the development costs are huge and need to be recuperated, so cost-of-materials isn't reflective of true cost, but insulin - even the "premium" versions - is not those and so this is gouging, coupled with literally paying other companies to not produce generics which should be a clear monopoly law violation.